Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women

By Christodoulakos G. E.   Lambrinoudaki I. V.   Creatsa M. G.   Economou E. V.   Siasou Z.   Panoulis C. P.   Kalligerou I.   Papadias C.  

Climacteric, Vol. 11, Iss. 2, 2008-01 ,pp. : 155-165

Informa Healthcare

Access to resources Recommend Favorite

Differential effects of unopposed versus opposed hormone therapy, tibolone, and raloxifene on substance p levels

By Kukuvitis A.   Kourtis A.   Papaiconomou N.   Zournatzi V.   Makedos G.   Panidis D.  

Fertility and Sterility, Vol. 80, Iss. 1, 2003-07 ,pp. : 96-98

Elsevier

Access to resources Recommend Favorite

A case report of recurrent endometriosis following Tibolone hormone replacement therapy

By Sundar S. S.   Gornall R. J.   Kerr-Wilson R.   Swingler G. R.   Kinder R. B.   McCarthy K.  

Journal of Obstetrics & Gynaecology, Vol. 27, Iss. 4, 2007-01 ,pp. : 433-434

Informa Healthcare

Access to resources Recommend Favorite

A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment

By Conner P.   Christow A.   Kersemaekers W.   Söderqvist G.   Skoog L.   Carlström K.   Tani E.   Mol-Arts M.   Schoultz B. von  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 50-58

Informa Healthcare

Access to resources Recommend Favorite

Effect of hormone replacement therapy and tibolone on serum total homocysteine levels in postmenopausal women

By Christodoulakos G.E.   Panoulis C.P.C.   Lambrinoudaki I.V.   Dendrinos S.G.   Rizos D.A.   Creatsas G.C.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 112, Iss. 1, 2004-01 ,pp. : 74-79

Elsevier

Access to resources Recommend Favorite